A conformational switch controlling the toxicity of the prion protein.
Journal
Nature structural & molecular biology
ISSN: 1545-9985
Titre abrégé: Nat Struct Mol Biol
Pays: United States
ID NLM: 101186374
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
received:
01
12
2021
accepted:
06
07
2022
pubmed:
11
8
2022
medline:
16
8
2022
entrez:
10
8
2022
Statut:
ppublish
Résumé
Prion infections cause conformational changes of the cellular prion protein (PrP
Identifiants
pubmed: 35948768
doi: 10.1038/s41594-022-00814-7
pii: 10.1038/s41594-022-00814-7
pmc: PMC9371974
doi:
Substances chimiques
Antibodies
0
Ligands
0
PrPC Proteins
0
Prion Proteins
0
Prions
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
831-840Subventions
Organisme : Biotechnology and Biological Sciences Research Council
Pays : United Kingdom
Informations de copyright
© 2022. The Author(s).
Références
Brandner, S. et al. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379, 339–343 (1996).
doi: 10.1038/379339a0
Lakkaraju, A. K. K. et al. Loss of PIKfyve drives the spongiform degeneration in prion diseases. EMBO Mol. Med. 13, e14714 (2021).
McNally, K. L., Ward, A. E. & Priola, S. A. Cells expressing anchorless prion protein are resistant to scrapie infection. J. Virol. 83, 4469–4475 (2009).
doi: 10.1128/JVI.02412-08
Wulf, M. A., Senatore, A. & Aguzzi, A. The biological function of the cellular prion protein: an update. BMC Biol. 15, 34 (2017).
doi: 10.1186/s12915-017-0375-5
Bueler, H. et al. Mice devoid of PrP are resistant to scrapie. Cell 73, 1339–1347 (1993).
doi: 10.1016/0092-8674(93)90360-3
Heppner, F. L. et al. Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies. Science 294, 178–182 (2001).
doi: 10.1126/science.1063093
Sonati, T. et al. The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein. Nature 501, 102–106 (2013).
doi: 10.1038/nature12402
Herrmann, U. S. et al. Prion infections and anti-PrP antibodies trigger converging neurotoxic pathways. PLoS Pathog. 11, e1004662 (2015).
doi: 10.1371/journal.ppat.1004662
Reimann, R. R. et al. Differential toxicity of antibodies to the prion protein. PLoS Pathog. 12, e1005401 (2016).
doi: 10.1371/journal.ppat.1005401
Frontzek, K. et al. Neurotoxic antibodies against the prion protein do not trigger prion replication. PLoS ONE 11, e0163601 (2016).
doi: 10.1371/journal.pone.0163601
Bardelli, M. et al. A bispecific immunotweezer prevents soluble PrP oligomers and abolishes prion toxicity. PLoS Pathog. 14, e1007335 (2018).
doi: 10.1371/journal.ppat.1007335
Baral, P. K. et al. Structural studies on the folded domain of the human prion protein bound to the Fab fragment of the antibody POM1. Acta Crystallogr. Sect. D Biol. Crystallogr. 68, 1501–1512 (2012).
doi: 10.1107/S0907444912037328
Mahal, S. P. et al. Prion strain discrimination in cell culture: the cell panel assay. Proc. Natl Acad. Sci. USA 104, 20908–20913 (2007).
doi: 10.1073/pnas.0710054104
Falsig, J. et al. A versatile prion replication assay in organotypic brain slices. Nat. Neurosci. 11, 109–117 (2008).
doi: 10.1038/nn2028
Nuvolone, M. et al. Strictly co-isogenic C57BL/6J-Prnp
doi: 10.1084/jem.20151610
Fischer, M. et al. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J. 15, 1255–1264 (1996).
doi: 10.1002/j.1460-2075.1996.tb00467.x
Perrier, V. et al. Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation. J. Neurochem. 89, 454–463 (2004).
doi: 10.1111/j.1471-4159.2004.02356.x
White, A. R. et al. Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 422, 80–83 (2003).
doi: 10.1038/nature01457
Simonelli, L. et al. Mapping antibody epitopes by solution NMR spectroscopy: practical considerations. Methods Mol. Biol. 1785, 29–51 (2018).
doi: 10.1007/978-1-4939-7841-0_3
Wang, J. et al. A human bi-specific antibody against Zika virus with high therapeutic potential. Cell 171, 229–241(2017).
doi: 10.1016/j.cell.2017.09.002
Lakkaraju, A. K. et al. Loss of PIKfyve drives the spongiform degeneration in prion diseases. EMBO Mol. Med. 13, e14714 (2021).
doi: 10.15252/emmm.202114714
Brody, A. H. & Strittmatter, S. M. Synaptotoxic signaling by amyloid beta oligomers in Alzheimer’s disease through prion protein and mGluR5. Adv. Pharm. 82, 293–323 (2018).
doi: 10.1016/bs.apha.2017.09.007
Rincon, M. Y. et al. Widespread transduction of astrocytes and neurons in the mouse central nervous system after systemic delivery of a self-complementary AAV-PHP.B vector. Gene Ther. 25, 83–92 (2018).
doi: 10.1038/s41434-018-0005-z
Herrmann, U. S. et al. Structure-based drug design identifies polythiophenes as antiprion compounds. Sci. Transl. Med. 7, 299ra123 (2015).
doi: 10.1126/scitranslmed.aab1923
Polymenidou, M. et al. The POM monoclonals: a comprehensive set of antibodies to non-overlapping prion protein epitopes. PLoS One 3, e3872 (2008).
doi: 10.1371/journal.pone.0003872
Ballmer, B. A. et al. Modifiers of prion protein biogenesis and recycling identified by a highly parallel endocytosis kinetics assay. J. Biol. Chem. 292, 8356–8368 (2017).
doi: 10.1074/jbc.M116.773283
Yang, J. et al. The I-TASSER Suite: protein structure and function prediction. Nat. Methods 12, 7–8 (2015).
doi: 10.1038/nmeth.3213
Berendsen, H. J. C., van der Spoel, D. & van Drunen, R. GROMACS: a message-passing parallel molecular dynamics implementation. Comput. Phys. Commun. 91, 43–56 (1995).
doi: 10.1016/0010-4655(95)00042-E
Hornemann, S., von Schroetter, C., Damberger, F. F. & Wuthrich, K. Prion protein-detergent micelle interactions studied by NMR in solution. J. Biol. Chem. 284, 22713–22721 (2009).
doi: 10.1074/jbc.M109.000430
Hornemann, S., Christen, B., von Schroetter, C., Perez, D. R. & Wuthrich, K. Prion protein library of recombinant constructs for structural biology. FEBS J. 276, 2359–2367 (2009).
doi: 10.1111/j.1742-4658.2009.06968.x
Zahn, R., von Schroetter, C. & Wuthrich, K. Human prion proteins expressed in Escherichia coli and purified by high-affinity column refolding. FEBS Lett. 417, 400–404 (1997).
doi: 10.1016/S0014-5793(97)01330-6
Frontzek, K. et al. Autoantibodies against the prion protein in individuals with PRNP mutations. Neurology 2020, 1–10 (2020).
Hussain, R. et al. CDApps: integrated software for experimental planning and data processing at beamline B23, Diamond Light Source. Corrigendum. J. Synchrotron Radiat. 22, 862 (2015).
doi: 10.1107/S1600577515007602
Provencher, S. W. & Glockner, J. Estimation of globular protein secondary structure from circular dichroism. Biochemistry 20, 33–37 (1981).
doi: 10.1021/bi00504a006